MedPath

The Application of Virtual Reality Goggles During Pleural Catheter Insertion

Not Applicable
Completed
Conditions
Pain; Catheter (Other)
Registration Number
NCT07027917
Lead Sponsor
Aydin Adnan Menderes University
Brief Summary

The aim of this study is to examine the effects of virtual reality glasses applied to individuals who will undergo pleural catheter placement on pain, anxiety, and vital parameters. The main research questions that the study aims to answer are as follows:

* Does the application of virtual reality goggles have an effect on pain measured during pleural catheter insertion?

* Does the application of virtual reality goggles have an effect on anxiety measured during pleural catheter insertion?

* Does the application of virtual reality goggles have an effect on the vital parameters measured during pleural catheter insertion?

The researcher compared the intervention and control groups to determine whether the glasses have an effect on the measurable parameters (pain, anxiety, and vital signs).

Detailed Description

Today, both pharmacological and non-pharmacological methods are used to reduce patients' pain and anxiety during invasive procedures. Distraction techniques hold an important place among non-pharmacological methods. Virtual reality (VR) glasses can be effective in reducing perceived pain and anxiety by allowing patients to divert their attention elsewhere during procedures.

This study was conducted to evaluate the distribution of virtual reality brightness on patients' pain and anxiety levels.

The study was designed as a randomized controlled trial by the researchers. The patients included in the study were divided into two groups: the intervention group (exposed to virtual reality) and the control group (standard care). Following stratified randomization, randomization was carried out using a simple random number table.

Application:

During the insertion phase, Shinecon brand virtual reality glasses were placed on the patients during the connection process, and underwater images were shown.

During routine phases, no distraction method was applied, and only the procedure was followed.

All patients' vital signs (blood pressure, heart rate, oxygen saturation) were recorded before, during, and after the procedure. Pain levels were assessed using the Visual Analog Scale (VAS) before and after the procedure. Additionally, anxiety levels were measured using the State-Trait Anxiety Inventory (STAI-S, STAI-T) before and after the procedure.

This study supports the use of virtual reality technology as a non-pharmacological intervention to improve patient comfort during minimally invasive procedures and provides evidence-based information.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria

Written or verbal consent to participate, Being over 18 years of age, Not having any psychiatric diagnosis, Not having any problems with vision, hearing, perception or communication.

Exclusion Criteria

Being unconscious Experiencing pain due to any other problem

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain severityFrom immediately before to 10 minutes after catheter insertion

Pain severity will be assessed using the Visual Analog Scale (VAS), a 10 cm scale ranging from 0 (no pain) to 10 (worst possible pain), measurements will be taken before, during and after pleural catheter insertion.

Secondary Outcome Measures
NameTimeMethod
Anxiety levelFrom immediately before to 10 minutes after catheter insertion

Anxiety will be measured using the State-Trait Anxiety Inventory (STAI). The inventory consist of 20 items rated on a 4 point Likert scale ranging from 1 (not at all), to 4 (very much so). The state anxiety subscale will be pre and post intervention to evaluate changes in situational anxiety levels.

Trial Locations

Locations (1)

Aydın Adnan Menderes Üniversitesi

🇹🇷

Aydın, Merkez, Turkey

Aydın Adnan Menderes Üniversitesi
🇹🇷Aydın, Merkez, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.